Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-04-08

FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)

View source ↗

Summary

FDA approved a supplemental application for verapamil hydrochloride, resulting in changes to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Verapamil Hydrochloride (Verapamil hydrochloride)

Snippet

SUPPL AP for VERAPAMIL HYDROCHLORIDE (VERAPAMIL HYDROCHLORIDE)